Pfizer to Pay $190M in Class Action Settlement over Generic Neurontin

BlogNewsletter   |   April 23, 2014

A $190 million settlement has been reached in New York in a consumer fraud class action lawsuit pending against Pfizer which alleges the pharma giant engaged in tactics to delay market entry of generic versions of its epilepsy drug Neurontin. The lawsuit … Continue reading

Despite Hiding Evidence, Takeda Challenges $6B Actos Verdict

BlogUncategorized   |  

Despite evidence that it concealed cancer risks associated with its diabetes drug Actos, Japanese drug maker Takeda Pharmaceutical Co. Ltd. said it would contest $6 billion in punitive damages imposed against it and Eli Lilly & Co. A federal jury ordered Takeda … Continue reading

Chicago Stroke Victim Awarded $14M after Taking Yasmin

Blog   |   April 22, 2014

A Chicago woman who suffered a severe stroke 13 days after starting the controversial birth control medication Yasmin has been awarded $14 million in a medical malpractice lawsuit against the doctor who prescribed the medication.  Dr. Zbigniew Aniol wrote the … Continue reading

How to Stand Out From Your Competition

Blog   |   April 19, 2014

By Ken Hardison, the President and founder of PILMMA, the Personal Injury Lawyers Marketing & Management Association www.pilmma.org. Imitation may be the sincerest form of flattery. But when it comes to marketing your law firm and beating your competition, it … Continue reading